SEC Form 4 · accession 0001567619-18-001675
ANGIODYNAMICS INC · ANGO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen A Trowbridge
Officer — SVP and General Counsel
Period of report
Jul 12, 2018
Accepted (ET)
Aug 22, 2018 · 7:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001275187
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 12, 2018 | M | 3,556 | $0.00 | A | 40,110 | D | |
| Common StockF2 | Jul 12, 2018 | F | 1,175 | $20.50 | D | 38,935 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Performance RightF3 | — | Jul 12, 2018 | M | 5,737 | D | — | — | Common Stock | 5,737 | 0 | D |
Explanation of responses
- F1This acquisition of 3,556 shares of common stock ("Common Stock") of AngioDynamics, Inc. (the "Company"), represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on July 22, 2015.
- F2The exempt disposition of 1,175 shares of Common Stock of the Company was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on July 22, 2015.
- F3On July 22, 2015, the reporting person received a target grant of 5,737 performance share units vesting between 0% and 200%. The performance of this award was based on the Company's total shareholder return relative to a peer group of companies over a three-year period covering the Company's fiscal years 2016, 2017 and 2018. Based on the Company's performance over this period, 3,556 shares of Common Stock were issued to the reporting person under this grant.